Caprion

Accelerating precision medicine™

About Us

Founded in 2002, Caprion Biosciences, is a leading specialty clinical research organization (CRO) laboratory providing state-of-the-art integrated platforms in proteomics and immune monitoring services to the pharmaceutical and biotechnology industry.

Located in Montreal, Canada and in Gosselies, Belgium, Caprion has been partnering with some of the largest pharmaceutical and most prominent biotech companies for more than 15 years. Caprion Biosciences, a privately-held company, is majority owned by Global Healthcare Opportunities, or GHO Capital Partners LLP.

Integrated Technology Platforms

ImmuneCarta®, is a proprietary immune monitoring platform offering multiparametric flow cytometry for comprehensive functional and phenotypical analyses of complex innate and adaptive immune responses with up to 17 parameters. Our platform provides advanced immune monitoring for all stages of clinical development of vaccines, biologics and immune-therapy trials and can rapidly develop, validate and deploy customized complex assays for clinical immune monitoring studies.

ProteoCarta™, offers proprietary gel-free, label-free mass spectrometry (LC-MS/MS) for comprehensive, quantitative and robust comparative measurement of proteins across large sets of biological samples for the discovery and validation of protein biomarkers.

Caprion's capabilities allow us to perform both complete studies and biologics-focused services for our clients.

Additionally, Caprion’s expertise allows us to provide our clients with both “off-the-shelf” and custom-made assays.

A Scientific Team with Broad Expertise in Immuno-Oncology

At Caprion, our scientific team has developed a broad expertise working on complex immune-oncology assays and partnering with clients on a variety of other disease areas such as:

  • Autoimmune diseases
  • Cardiovascular
  • Metabolic
  • Neurology
  • Infectious diseases

Broad Sample Processing Capabilities

Our extensive sample processing capabilities allows us to work with various sample matrices:

  • Plasma
  • Serum
  • CSF
  • Cells
  • Tissue
  • Formalin fixed paraffin embedded
  • Sputum

Highest Quality Standards

With close to two decades of operations, Caprion is committed to providing the highest quality in project management with its ISO and GMP accreditations and is also registered by CLIA for specific testing methods. Caprion’s multi-disciplinary team of scientists utilizes a proprietary approach to industrialized proteomics that reduces variability and achieves significant results. Applied standards to procedures; from sample collection. mass spectrometry to data analysis provide clients with reproducible data that is validated across large sets of clinical samples with rapid development and deployment MRM (Multiple Reaction Monitoring). These results have validated the processed used of industrialized proteomics and immune monitoring approach from pre-clinical and clinical phases of drug development. Analysis of phenotypic and functional profiles of innate and adaptive immune responses according to GCP/GLP/GCLP and ISO standards allows clients to apply Caprion's multiparametric immune monitoring expertise across multiple therapeutic areas.

Our Partnerships

In addition to the broad range of pharmaceutical and biotech sponsored programs, Caprion has been awarded two consecutive 5-year US$13 million contracts for infectious diseases research with the NIH-NIAID Biodefense Proteomics Research Program, and has been selected as a partner of The Foundation for the National Institutes of Health's (NIH) Biomarkers Consortium.